MarketPeel
Insider Trading Intelligence
Pricing
…
BL

Brian Lian

VKTX
PRESIDENT & CEO · VIKING THERAPEUTICS, INC. · CIK 0001614578
FILING MIX · LIFETIME38%/62%
BUYS
40
SELLS
66
TOTAL VALUE
$111.21M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
2,546,967
AVG SELL PX
$35.15
TRADE KIND
SHOWING 106 / 106
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
35 backtested trades · 8 horizons · 23 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brian Lian, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d35+60.00%+0.05%-0.06%+0.11%-1.88%0.09
14d35+37.14%+6.33%+0.44%+5.90%+5.77%2.42
30d35+37.14%+48.10%+1.71%+46.38%+7.83%3.43
60d35+34.29%+46.95%+3.57%+43.38%+4.84%3.06
90d35+54.29%+38.99%+3.52%+35.47%-9.99%2.24
180d35+60.00%+3.87%+6.84%-2.97%-39.07%-0.27
1y35(5 pending)+40.00%+69.12%+21.47%+47.65%-9.40%1.74
2y35(18 pending)+35.29%+19.14%+39.68%-20.54%-18.04%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VKTX · 2,546,967 shares · as of Jan 5, 2026
0683,1751,366,3502,049,5252,732,700202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 40 buys / 66 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
132,454$32.29$4.28M2,600,246Jan 5, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
6,400$35.07$224.4K2,499,291Jan 5, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
41,276$34.22$1.41M2,505,691Jan 5, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
53,279$33.38$1.78M2,546,967Jan 5, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
224,080——2,732,700Jan 2, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
78,400——2,508,620Jan 2, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
176,300——176,300Jan 2, 2026Jan 5, 2026 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
38,989$35.01$1.36M2,419,109Oct 28, 2025Oct 28, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,084——2,458,098Oct 27, 2025Oct 28, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
26,889$27.80$747.6K2,388,014Jul 3, 2025Jul 3, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
48,333——2,414,903Jul 2, 2025Jul 3, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
175,490$42.68$7.49M2,385,570Jan 6, 2025Jan 6, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
19,000$43.32$823.0K2,366,570Jan 6, 2025Jan 6, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
92,800——2,397,727Jan 3, 2025Jan 6, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
78,300——78,300Jan 3, 2025Jan 6, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
163,333——2,561,060Jan 3, 2025Jan 6, 2025 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
119,874$71.15$8.53M2,305,127Sep 20, 2024Sep 20, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
200$71.99$14.4K2,304,927Sep 20, 2024Sep 20, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
96,056$70.43$6.77M2,425,001Sep 20, 2024Sep 20, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
166,130$7.77$1.29M2,521,057Sep 20, 2024Sep 20, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
166,130——65,000Sep 20, 2024Sep 20, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
1,000$7.77$7.8K2,355,927Aug 21, 2024Aug 22, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
1,000——231,130Aug 21, 2024Aug 22, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,000$69.90$69.9K2,354,927Aug 21, 2024Aug 22, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
112,870$7.77$877.0K2,467,797Aug 19, 2024Aug 19, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,296$67.12$758.2K2,354,927Aug 19, 2024Aug 19, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
112,870——232,130Aug 19, 2024Aug 19, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
31,442$66.37$2.09M2,366,223Aug 19, 2024Aug 19, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
70,132$65.33$4.58M2,397,665Aug 19, 2024Aug 19, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
65,941$56.95$3.76M2,404,845Jul 30, 2024Jul 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
30,417$58.78$1.79M2,354,927Jul 30, 2024Jul 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
19,501$57.81$1.13M2,385,344Jul 30, 2024Jul 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
41,000——2,307,453Jul 29, 2024Jul 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
163,333——2,470,786Jul 29, 2024Jul 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
153,948$83.34$12.83M2,266,453Mar 27, 2024Mar 27, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
221,667——2,420,401Mar 27, 2024Mar 27, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
162,815$85.22$13.88M2,198,734Mar 1, 2024Mar 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
221,667——2,361,549Mar 1, 2024Mar 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
45,000$29.90$1.35M2,139,882Feb 9, 2024Feb 9, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
80,000$26.95$2.16M2,264,882Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,000$27.45$1.10M2,224,882Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
140,000$4.65$651.0K2,404,882Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
14,148——0Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
140,000——0Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
49,079$1.23$60.4K2,313,961Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
60,000$25.95$1.56M2,344,882Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,000$28.90$1.16M2,184,882Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
34,931——0Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
49,079$25.75$1.26M2,264,882Feb 8, 2024Feb 8, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
45,000$24.95$1.12M2,264,882Jan 31, 2024Jan 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
85,000$1.23$104.5K2,349,882Jan 31, 2024Jan 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
40,000$24.45$978.0K2,309,882Jan 31, 2024Jan 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
85,000——14,148Jan 31, 2024Jan 31, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
35,000$1.23$43.0K2,299,882Jan 30, 2024Jan 30, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
35,000——99,148Jan 30, 2024Jan 30, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
35,000$23.95$838.3K2,264,882Jan 30, 2024Jan 30, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
39,552$18.58$734.9K2,264,882Jan 4, 2024Jan 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000——2,359,074Jan 3, 2024Jan 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
360,000——360,000Jan 3, 2024Jan 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
160,000——2,410,549Jan 3, 2024Jan 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
108,525$17.40$1.89M2,250,549Jan 3, 2024Jan 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
106,115$17.40$1.85M2,304,434Jan 3, 2024Jan 4, 2024 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
45,000$22.45$1.01M2,197,963May 1, 2023May 1, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
35,000$21.45$750.8K2,242,963Apr 19, 2023Apr 21, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
125,000——0Apr 17, 2023Apr 18, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
155,000$20.45$3.17M2,277,963Apr 17, 2023Apr 18, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
125,000$2.15$268.8K2,432,963Apr 17, 2023Apr 18, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
54,336——0Apr 13, 2023Apr 13, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
79,336$18.45$1.46M2,307,963Apr 13, 2023Apr 13, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
54,336$1.88$102.2K2,387,299Apr 13, 2023Apr 13, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
300,000——2,532,963Apr 3, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
22,000$17.85$392.7K2,232,963Apr 3, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
200,000$17.57$3.51M2,332,963Apr 3, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
67,970——0Mar 31, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
67,970$9.49$645.0K2,322,933Mar 31, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
67,970$17.45$1.19M2,254,963Mar 31, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
115,852$1.23$142.5K2,388,815Mar 30, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASE
President & CEO
19,530$9.49$185.3K2,408,345Mar 30, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
115,852——134,148Mar 30, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
88,000$16.95$1.49M2,320,345Mar 30, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
65,382$17.45$1.14M2,254,963Mar 30, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
19,530——67,970Mar 30, 2023Apr 3, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
28,619$8.42$241.0K2,272,963Jan 4, 2023Jan 4, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
68,252$8.52$581.5K2,301,582Jan 3, 2023Jan 4, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
266,667——2,369,834Jan 3, 2023Jan 4, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
600,000——600,000Jan 3, 2023Jan 4, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
66,127$9.40$621.6K2,103,167Dec 30, 2022Jan 4, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
121,667——2,169,294Dec 30, 2022Jan 4, 2023 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
26,432$4.62$122.1K2,036,686Jan 4, 2022Jan 5, 2022 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
173,333——2,063,118Jan 3, 2022Jan 5, 2022 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
36,319$4.88$177.2K1,889,785Jan 3, 2022Jan 5, 2022 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
390,000——390,000Jan 3, 2022Jan 5, 2022 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
27,750$6.50$180.4K1,924,807Sep 28, 2021Sep 30, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
55,500——1,952,557Sep 28, 2021Sep 30, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
5,611$6.68$37.5K1,894,181Jan 19, 2021Jan 19, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
164,000——1,876,432Jan 4, 2021Jan 6, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
16,973$5.80$98.4K1,899,792Jan 4, 2021Jan 6, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
369,000——369,000Jan 4, 2021Jan 6, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,333——1,916,765Jan 4, 2021Jan 6, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
31,545$5.63$177.6K1,712,432Jan 3, 2021Jan 6, 2021 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
19,192$6.25$120.0K1,742,363Sep 15, 2020Sep 16, 2020 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
55,500——1,761,555Sep 15, 2020Sep 16, 2020 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
3,195$7.18$22.9K1,704,312Jan 19, 2020Jan 21, 2020 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
SALE
President & CEO
6,782$7.77$52.7K1,707,507Jan 3, 2020Jan 3, 2020 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
153,333——1,714,289Jan 3, 2020Jan 3, 2020 ↗View →
VKTX
VIKING THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
345,000——345,000Jan 3, 2020Jan 3, 2020 ↗View →
Other insiders · VKTX
Loading peer insiders…
About this filer
CIK 0001614578
ROLE
President & CEO
PRIMARY
VKTX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001614578DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback